INTRODUCTION
cated in the mitochondria that scavenges free radicals, protecting cells from oxidative damage. Because it requires Mn to function, Mn concentrations in the diet have been shown to directly affect Mn-SOD mRNA expression, protein concentration, and activity in the heart, and these have been proposed to be good markers of Mn bioavailability (Li et al., 2004; Luo et al., 2007; Li et al., 2011) .
Because of its importance in growth and metabolism, Mn is supplemented in animal feeds and is exceedingly important for rapid-growing broiler chickens. Organic and inorganic Mn sources are used for broiler diet supplementation and there are conflicting findings on the bioavailability of each (Baker and Halpin, 1987; Henry et al., 1989; Scheideler, 1991; Luo et al., 2007) . Manganese sulfate (MnSO 4 ) is a common inorganic Mn supplement source and has been shown to have the highest bioavailability of the common existing inorganic manganese supplements (Black et al., 1984a; Henry et al., 1986) .
To determine the tolerability of a newly developed inorganic Mn source, tribasic manganese chloride [TBMC; Mn 2 (OH) 3 Cl, also referred to as manganese hydroxy chloride], we compared the effects of pharmacological doses of TBMC and MnSO 4 ranging from 3,600 to 5,400 ppm on performance, plasma Mn concentration, and mortality. To assess the efficacy of TBMC as an alternative supplement, we compared the growth performance, bone, liver, and bile mineral content, and heart Mn-SOD activity, protein, and relative mRNA abundance in broiler chicks supplemented with graded levels of TBMC to that of animals supplemented with equivalent amounts of MnSO 4 .
MATERIALS AND METHODS

Experiment 1-Tolerance
All procedures were approved by the University of Georgia Institutional Animal Care and Use Committee. Male broiler chicks were obtained at day of hatch from a local hatchery (Cobb 500, Cobb-Vantress Hatchery, Cleveland, GA) and assigned to 1 of 7 treatments (n = 8 pens/treatment; n = 20 birds/pen). Birds were housed in floor pens containing recycled pine wood shavings in a thermostatically controlled room with ad libitum access to feed and water for 35 d. Birds were maintained on a 24-h constant light schedule for 3 d followed by a 23-h light schedule, with the light intensity decreased by 75% for the remainder of the experiment. Treatments included a corn-soybean meal basal diet formulated to meet or exceed nutrient requirements for growing broiler chickens (NRC, 1994) and the basal diet supplemented with TBMC or MnSO 4 at 3,600, 4,500, or 5,400 ppm supplemental Mn (Table 1) at the expense of sand. Birds were fed their respective treatment diets in the form of a starter diet from d 1 to 21, followed by a grower diet from d 22 to 35. Body weight was measured at 0, 6, 21, and 35 d, and cumulative feed intake was measured from 6 to 20 and 21 to 35 d. At d 35, 2 birds from each pen were randomly selected for blood collection by cardiac puncture for plasma Mn analysis and all birds were then euthanized by cervical dislocation. Plasma Mn was analyzed by a commercial laboratory following standard methods described in Anderson (1999;  Central Analytical Labs, University of Arkansas, Fayetteville).
Experiment 2-Bioavailability-Tissue Mn
All procedures were approved by the California Polytechnic State University Institutional Animal Care and Use Committee. Broiler chicks were obtained at day of hatch from a commercial hatchery (Cobb × Cobb, Foster Farms, Fresno, CA) and randomly assigned to 1 of 7 treatments (n = 6 pens/treatment; n = 6 birds/ pen). Birds were housed in thermostatically controlled Petersime batteries with raised wire floors and maintained on a 24-h constant light schedule with ad libitum access to feed and deionized water for 21 d. Treatments included a corn-soybean meal basal diet formulated to meet or exceed nutrient requirements, except for Mn, for growing broiler chickens (NRC, 1994) and the basal diet supplemented with TBMC or MnSO 4 at 30, 60, or 130 ppm Mn at the expense of cellulose (celufill). The basal diet contained 45 ppm Mn whereas the 30, 60, and 130 ppm TBMC diets contained 79, 109, and 183 ppm Mn, respectively, and the 30, 60, and 130 ppm MnSO 4 diets contained 70, 98, and 184 ppm Mn, respectively.
The basal diet was supplied to all pens for 9 d to promote maximal absorption of Mn followed by 12 d of the assigned treatment diets. Body weight of each bird was measured on day of hatch, the first day of the treatment period, and the final day of the study. Twenty-four-hour feed intake was measured at 3 time points during the treatment period. Cumulative feed intake was measured from d 1 to 9 and d 10 to 21. Birds were euthanized by CO 2 asphyxiation followed by cervical dislocation at 21 d for tissue sample collection. Feed was removed 2 to 4 h before euthanasia and tissues were collected from fasted animals to ensure presence of bile for collection. The right tibia was removed, stripped of soft tissue, and placed in a Whirl-Pak bag (Fisher Scientific, Pittsburgh, PA). The left lobe of the liver was removed and placed in a Whirl-Pak bag. The bile was collected from the gall bladder using a borosilicate glass Pasteur pipet (Fisher Scientific) and stored in a sterile borosilicate collection tube (Kendall-Covidien, Mansfield, MA). All tissues were stored at −20°C until analyzed for Al, Cu, Ca, Fe, K, Mg, Mn, Na, P, S, and Zn by inductively coupled plasma analysis (by a commercial laboratory following standard methods described in Anderson, 1999 ; Central Analytical Labs, University of Arkansas, Fayetteville). Samples were taken from 2 birds from each pen for analysis and values within pen were averaged for statistical analysis.
Experiment 3-Bioavailability-MnSOD
All procedures were approved by the University of Georgia Institutional Animal Care and Use Committee. Male broiler chicks were obtained at day of hatch from a local hatchery (Cobb 500, Cobb-Vantress Hatchery) and placed in Petersime batteries with raised wire floors. Birds were maintained on a 24-h constant light schedule and provided ad libitum access to feed and water for 21 d. At d 7, birds were assigned to 1 of 9 treatments (n = 8 pens/treatment; n = 7 birds/pen). Treatments included a corn-soybean meal basal diet formulated to meet or exceed nutrient requirements, except for Mn, for growing broiler chickens (NRC, 1994) and the basal diet supplemented with TBMC or MnSO 4 at 60, 120, 180, and 240 ppm Mn. The basal diet contained 43 ppm Mn whereas the 60, 120, 180, and 240 ppm TBMC diets contained 128, 183, 209, and 281 ppm Mn, respectively, and the 60, 120, 180, and 240 ppm MnSO 4 diets contained 120, 177, 218, and 319 ppm Mn, respectively.
All birds were supplied with the basal diet for 7 d to promote maximal absorption of Mn followed by their respective treatment diets for 14 d. Body weight was measured at 7, 14, and 21 d. Cumulative feed intake was measured for d 6 to 21. At 21 d, birds were weighed and one bird per pen was euthanized by cervical dislocation, and heart tissue was immediately excised. One subsample of heart was placed in a plastic bag and immediately stored at −20°C until analysis of Mn-SOD activity and protein abundance by Western blotting. A second subsample was placed into RNA stabilization solution and snap frozen in liquid nitrogen until analysis of Mn-SOD mRNA abundance.
Protein and RNA Extraction. Five hundred milligrams of frozen heart tissue in 4.5 mL of sucrose buffer (50 mM sucrose, 200 mM mannitol, 1 mM EDTA, 10 mM TRIS buffer, pH 7.4) was homogenized on ice with an adaptable homogenizer (VDI 25, VWR, Radnor, PA) for 30 s at 25,500 × g. The homogenate was centrifuged at 10,000 × g for 15 min at 4°C, and the supernatant was stored at −20°C until analysis of Mn-SOD activity and protein abundance by Western blot. Protein content was measured using the Bradford protein assay (Bio-Rad protein assay solution; Bio-Rad Laboratories, Richmond, CA) using bovine serum albumin (BSA) as the standard.
Total RNA in heart tissue was isolated using Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. The RNA concentration was estimated by measuring UV light absorbance at 260 nm (Nanodrop spectrophotometer, Wilmington, DE).
Mn-SOD Activity. The activities of total Mn-SOD were assessed using a commercial assay kit (Northwest Life Science Specialties, Vancouver, Canada) according to the manufacturer's instructions and determined by UV absorbance at 550 nm with a multilabel counter (Wallac 1420, PerkinElmer Life and Analytical Sciences, Turku, Finland). One sample from each of 4 pens per treatment was analyzed in triplicate and the triplicate values were averaged within pen for statistical analysis.
Western Blotting. Protein (200 μg) was separated by SDS-PAGE (16% resolving gels and 4% stacking gels). Proteins were then transferred to nitrocellulose membranes and blocked overnight at 4°C in 5% nonfat milk in phosphate-buffered saline Tween-20 (PBST). The membranes were incubated in a 1:2,000 dilution of rabbit polyclonal superoxide dismutase (SOD) 2 antibodies (ABcam, Cambridge, MA) and a 1:5,000 dilution of rabbit polyclonal glyceraldehyde 3-phosphate dehydrogenase (GAPDH; ABcam, Cambridge, MA) for 1 h. The membranes were washed 4 times in PBST, 15 min per wash, to remove residual primary antibody. The washed membranes were incubated with a goat anti-rabbit polyclonal antibody conjugated to alkaline phosphatase (Invitrogen Life Technologies). The membranes were washed 4 times for 15 min each in PBST and developed with enhanced chemiluminescence Western reagent. Nonsaturated images were captured using an ultra-Lum (Claremont, CA) imaging system. Densitometric quantification of the Western blot images was performed using Ultraquant 6.0 software (Ultra-Lum, Claremont, CA). Values were normalized with the internal control GAPDH. One sample from each of 3 pens per treatment was analyzed.
Quantitative Reverse-Transcription PCR. The relative abundance of Mn-SOD mRNA was determined using a semiquantitative reverse-transcription (RT) PCR method. Reverse transcription was performed using the Taqman RT reagents according to the methods described in manufacturer's instructions (Applied Biosystems Life Technologies Corp., Carlsbad, CA). The RT reaction was performed by incubating the sample at 25°C for 10 min, followed by 37°C for 60 min, and 95°C for 5 min (Veriti Thermocycler ABI). For the real-time PCR, Taqman universal PCR master mix was used and the procedure was performed following the manufac-turer's instructions using SOD2 and GAPDH TaqMan gene expression assays (assay IDs Gg03363949_m1 and Gg03346982_m1; Applied Biosystems Life Technologies Corp.). The PCR amplification involved initial 2 min incubation at 50°C and at 95°C for 10 min, followed by 40 cycles at 95°C for 3 s and 60°C for 30 s (fast realtime PCR, Applied Biosystems, Foster City, CA). The relative standard curve method was used to quantify relative mRNA abundance according to the procedures described by manufacturer's guideline (fast real-time PCR, Applied Biosystems). The relative Mn-SOD mRNA abundance is presented as the relative intensity ratio (arbitrary units) between a fluorescent intensity of Mn-SOD mRNA and GAPDH mRNA. One sample from each of 3 pens per treatment was analyzed in triplicate and the triplicate values were averaged within pen for statistical analysis.
Statistical Analysis
All dependent variables were initially analyzed using a 2-way ANOVA with the GLM procedure (PROC GLM) of Statistical Analysis Software (SAS; version 9.2; SAS Institute Inc., Cary, NC) for the effects of Mn source, level, and their interaction within the 2 × 3 (experiments 1 and 2) or 2 × 4 (experiment 3) factorial arrangement of treatments that excluded comparison to the basal diet. When a main effect or interaction was significant in the 2-way ANOVA (P < 0.05) individual unadjusted means comparisons among each of the 6 treatment diets plus the basal diet were made using Student's t-test. Relative bioavailability was assessed using PROC GLM in SAS, as described by Littell et al. (1997) . All differences were considered significant at P < 0.05.
RESULTS
Experiment 1-Tolerance
Feed intake and initial BW did not differ between treatments (Table 2) . Mortality in birds supplemented with 3,600, 4,500, and 5,400 ppm Mn in the form of TBMC was 3.1%, 5.0%, and 2.5%, respectively, whereas mortality in birds supplemented with the same levels of Mn in the form of MnSO 4 was 4.4%, 6.9%, and 7.5%, respectively. Birds fed the basal diet had 2.5% mortality. There was no statistical significance found 2 Body weight was taken at 4 time points during the trial and cumulative feed intake was taken over 2 time periods. Two randomly selected birds from each pen were used for blood collection at d 35.
3 SE represents pooled standard error. 4 The effect of source (S), level (L), or interaction (S × L) among Mn-supplemented dietary treatments was considered significant at P < 0.05. (P > 0.20) in mortality, but there was a trend toward an effect of source such that the mortality of birds fed TBMC was lower than birds fed MnSO 4 at each level, and the overall mortalities were higher for MnSO 4 (P = 0.06). At all time points, BW was significantly higher in birds fed the basal diet than those supplemented with either Mn source (P < 0.05; Table 2 ). At 6 d, birds supplemented with 3,600 ppm Mn had higher BW than birds supplemented with 5,400 ppm Mn regardless of Mn source (P < 0.05; Table 2 ). Birds supplemented with TBMC had higher BW at d 6 than birds supplemented with MnSO 4 (P < 0.05; Table 2 ). At 21 d, BW was lower with higher dietary Mn concentration in birds supplemented with MnSO 4 (P < 0.05; Table 2) while there was no difference in BW among TBMC treatment groups. At 35 d, birds in the 5,400 ppm MnSO 4 treatment group had lower BW than birds in any other treatment group (P < 0.05; Table 2 ).
Plasma Mn differed significantly among treatments (P < 0.05; Table 2 ). Birds fed the basal diet had lower plasma Mn than all other treatments (P < 0.05; Table  2 ). Birds fed the highest level of MnSO 4 had higher levels of plasma Mn than all other treatments (P < 0.05; Table 2 ).
Experiments 2 and 3-Bioavailability
There was no significant effect of dietary treatment on feed intake or BW in either bioavailability experiment (Table 3, 4) . Neither Mn-SOD activity, nor protein, or relative mRNA abundance were affected by treatment (P > 0.20; Table 5 ).
The concentration of Mn in the tibia increased as dietary Mn increased; birds supplemented with 30 and 60 ppm Mn had a lower concentration of Mn in the tibia than birds supplemented with 130 ppm of dietary Mn regardless of the source of Mn (P < 0.05; Figure 1 ; Table 6 ). There was no significant effect on any other minerals analyzed in the tibia. The average values are as follows: Al was not detected; 354,666 ppm Ca; 1.2 ppm Cu; 322 ppm Fe; 11,596 ppm K; 7,057 ppm Mg; 12,748 ppm Na; 168,315 ppm P; 8,067 ppm S; and 402 ppm Zn.
Birds supplemented with 30 ppm Mn had lower liver Mn concentrations than birds supplemented with 60 or 130 ppm Mn (P < 0.05; Figure 2 ; Table 6 ). Liver Mg content was highest in birds supplemented with 130 ppm TBMC, whereas birds supplemented with 30 ppm TBMC or MnSO 4 had the lowest liver Mg (P < 0.05; Figure 2 ; Table 6 ). There was a significant effect of Mn level on liver P content, where 130 ppm TBMC and 60 ppm MnSO 4 led to elevated liver P (P < 0.05; Table  6 ), and while significant, these differences were minor in magnitude. There was no significant effect on any other minerals analyzed in the liver. The average values are as follows: 0.32 ppm Al; 283 ppm Ca; 10.8 ppm Cu; 870 ppm Fe; 10,924 ppm K; 4,990 ppm Na; 7,440 ppm S; and 96 ppm Zn.
Bile Zn content was higher in birds supplemented with 130 ppm Mn MnSO 4 than with any other treatment (P < 0.05; Table 6 ). The concentration of Mn in 1 All broilers were fed a basal diet for 6 d followed by a basal diet alone or supplemented with either TBMC or MnSO 4 . Heart tissue samples were taken at d 21 and used for determining Mn-SOD activity (n = 4) and mRNA (n = 3) and protein (n = 3) abundance. Values represent the mean per bird.
2 SE represents the pooled standard error. the bile increased as the level of dietary Mn concentration increased, though these differences were not significant (Figure 3 ). There was no significant effect of treatment on any other minerals analyzed in the bile.
The average values are as follows: Al was not detected; 670 ppm Ca; 4.0 ppm Cu; 0.58 ppm Fe; 655 ppm K; 123 ppm Mg; 0.31 ppm Mn; 3,981 ppm Na; 1,618 ppm P; 8,394 ppm S; and 2.5 ppm Zn.
DISCUSSION
The TBMC is similar to MnSO 4 in tolerability and bioavailability. The tolerance in experiment 1 was determined through measures of feed intake, mortality, BW, and plasma Mn concentration. Body weight and plasma Mn were significantly affected by diet. As dietary Mn increased, broiler BW decreased (P < 0.05; Table 2 ). Interestingly, Black et al. (1984a) examined Mn supplementation at 1,000, 2,000, and 4,000 ppm from 3 different sources, including MnSO 4 , and found no effect on BW. The levels in this study were higher (3,500, 4,500, and 5,400 ppm Mn), which may have contributed to differences in BW. Southern and Baker (1983) found a slight depression of weight gain at 3,000, 4,000, and 5,000 ppm supplemental Mn from 4 different sources, including MnSO 4 , however the depression was not as great as observed in this study. At all time points that BW was measured in the present study, broilers fed TBMC had equal or better performance than birds fed MnSO 4 , indicating that broilers better tolerate TBMC than MnSO 4 when fed at exceedingly high levels. Plasma Mn was higher in all supplemented diets compared with the basal, and the 5,400 ppm MnSO 4 diet resulted in the highest plasma Mn concentration (P < 0.05; Table 2 ). Black et al. (1984a) reported a linear increase in plasma Mn, with levels of supplemental dietary MnSO 4 ranging from 1,000 to 4,000 ppm, and the basis for this discrepancy is unclear. a-c Differing superscripts within a row indicate significant differences among Mn-supplemented dietary treatments. 1 All broilers were fed a basal diet for 9 d followed by the basal diet alone or supplemented with either TBMC or MnSO 4 ; n = 6 pens/diet. Values represent the mean per bird.
2 The right tibia, left lobe of the liver, and bile were collected at 21 d posthatch, and mineral concentrations were determined by inductively coupled plasma analysis.
3 SE represents the pooled standard error. 4 The effect of source (S), level (L), or interaction (S × L) among Mn-supplemented dietary treatments was considered significant at P < 0.05. As in previous studies, bone Mn increased as dietary Mn increased (P < 0.05; Figure 1 ), and others have used this as the basis for calculating bioavailability of Mn sources (Black et al., 1984a; Henry et al., 1986) . Liver Mn increased as dietary Mn increased up to 60 ppm dietary Mn (P < 0.05) but not significantly from 60 to 130 ppm (Figure 2) . Previous studies have shown levels of liver Mn continuously increasing in broilers fed up to at least 4,000 ppm Mn in the diet (Black et al., 1984a) , showing no level at which the liver stops taking up Mn. In the present study, there was a slight numerical increase in liver Mn content in the 130 ppm diet compared with the 60 ppm diet, and it may be that higher levels of supplementation would have led to greater content in the liver. Comparison of the relative bioavailability between MnSO 4 and TBMC using analyzed dietary Mn content and both tibia and liver Mn by regression slope comparison as described by Littell et al. (1997) revealed no significant difference between the 2 sources (P > 0.20).
Bile Mn was present even in birds supplemented with the lowest level, and this concentration increased with increasing Mn supplementation, though not significantly (Figure 3 ). Biliary excretion is the major regulatory process for Mn in the body and it occurs quickly in response to dietary Mn absorption (Brandt and Schramm, 1986) . A numerical increase in bile Mn content with increasing dietary Mn was also reported by Southern and Baker (1983) , though at much higher levels of dietary Mn. The continued incorporation into the bone and liver at higher levels is interesting when noticing the bile Mn increasing as well. Manganese uptake by tissues is through passive mediated transport and Mn status is regulated through biliary excretion, not through tissue uptake (Brandt and Schramm, 1986) . This may indicate that even at the lowest level of dietary Mn supplemented in these experiments, the tissues have an adequate supply of Mn to function normally, leading to excretion of excess in bile.
In experiment 3, Mn-SOD activity, as well as protein and relative mRNA abundance were measured based on previous reports proposing that transcription, translation, and posttranslational activation of the enzyme are regulated by Mn supply (Luo et al., 2007) . Our results showed no differences among treatments for any Mn-SOD parameters (Table 5 ). This outcome is interesting based on the few previous reports that Mn-SOD mRNA abundance is a reliable and sensitive indicator of level, and source differences of Mn and Mn-SOD activity has been shown to be level dependent (Luo et al., 2007; Li et al., 2011) . According to the results from this study, bone and liver manganese are better indicators of bioavailability, as Mn-SOD activity, protein, or relative mRNA abundance did not differ between sources or levels ranging from 0 to 240 ppm supplemental Mn. It should be noted that only 3 (for mRNA and protein) or 4 (for activity) replicates were analyzed for this study, possibly inflating the variation about these means and masking any significant effects.
Overall, the results from these experiments indicate that TBMC is an effective Mn supplement that appears to perform equally to MnSO 4 based on tissue Mn accumulation, BW, and feed intake. The TBMC also appears to be better tolerated than MnSO 4 at excessively high levels, based on differences in BW between broilers fed the 2 sources. The studies support the ideas from previous experiments that indicate Mn accumulation in the liver and bone increases with increasing dietary Mn. 
